Aptose Biosciences (TSE:APS) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$1.18 and traded as low as C$0.51. Aptose Biosciences shares last traded at C$0.51, with a volume of 1,510 shares.

Aptose Biosciences Stock Performance

The company has a debt-to-equity ratio of 670.80, a current ratio of 0.80 and a quick ratio of 5.41. The company’s fifty day simple moving average is C$0.60 and its two-hundred day simple moving average is C$1.18. The stock has a market cap of C$9.24 million, a price-to-earnings ratio of -0.09 and a beta of 1.36.

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) last released its quarterly earnings data on Thursday, August 8th. The biotechnology company reported C($0.59) earnings per share for the quarter, topping the consensus estimate of C($0.80) by C$0.21. On average, analysts forecast that Aptose Biosciences Inc. will post -0.59 earnings per share for the current year.

About Aptose Biosciences

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.